This inventor holds 1 USPTO granted patent. Top assignees: Astellas Pharma Gmbh, Chemo-Sero-Therapeutic Research Institute. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 425 
1 out of 151 Years Active: 2007
Title: Yoshiyuki Tokieda: Innovator in Recombinant Antibody Research
Introduction
Yoshiyuki Tokieda is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. His work focuses on addressing autoimmune diseases and related conditions.
Latest Patents
Yoshiyuki Tokieda holds a patent for a recombinant anti-osteopontin antibody. This innovative antibody is designed to inhibit the binding of integrins to osteopontin or its fragments. The patent outlines its potential use as a remedy for autoimmune diseases, rheumatism, and rheumatoid arthritis. Additionally, this antibody serves as a diagnostic tool for rheumatism, providing a method for diagnosing the condition.
Career Highlights
Throughout his career, Tokieda has worked with prominent organizations, including the Chemo-Sero-Therapeutic Research Institute and Astellas Pharma GmbH. His experience in these institutions has contributed to his expertise in antibody research and development.
Collaborations
Some of his notable coworkers include Toshimitsu Uede and Shigeyuki Kon. Their collaborative efforts have further advanced the research in the field of recombinant antibodies.
Conclusion
Yoshiyuki Tokieda's contributions to biotechnology, particularly through his patented recombinant anti-osteopontin antibody, highlight his role as an innovator in the medical field. His work has the potential to significantly impact the treatment and diagnosis of autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile